Absence of association between nailfold capillary findings and mild cognitive dysfunction in systemic lupus erythematosus-Reference-Cited by-同舟云学术

Absence of association between nailfold capillary findings and mild cognitive dysfunction in systemic lupus erythematosus

Published:2022-05-27 Issue:9 Volume:41 Page:2737-2743
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Munguía-Realpozo Pamela^ORCID,García-Carrasco Mario^ORCID,Mendoza-Pinto Claudia^ORCID,Galaviz-Silva María de Lourdes^ORCID,Etchegaray-Morales Ivet^ORCID,Méndez-Martínez Socorro^ORCID,Montiel-Jarquín Álvaro José^ORCID,Vázquez de Lara Luis G.^ORCID,Silveira Luis H.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-022-06215-x.pdf

Reference33 articles.

1. Al RH, Tani C, Kwan A, Marzouk S, Colosimo K, Medina-Rosas J et al (2018) What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. Semin Arthritis Rheum 48:240–255. https://doi.org/10.1016/j.semarthrit.2018.02.007

2. Unterman A, Nolte JES, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G (2011) Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 41:1–11. https://doi.org/10.1016/j.semarthrit.2010.08.001

3. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57:496–500. https://doi.org/10.1212/WNL.57.3.496

4. Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD et al (2012) Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum 42:179–185. https://doi.org/10.1016/j.semarthrit.2012.03.011

5. Seet D, Allameen NA, Tay SH, Cho J, Mak A (2021) Cognitive dysfunction in systemic lupus erythematosus: immunopathology, clinical manifestations, neuroimaging and management. Rheumatol Ther 8:651–679. https://doi.org/10.1007/s40744-021-00312-0